TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this cluster in csv format
Share this page

Variant cluster associations

Hospitalization Episode Statistics (HES)

Cluster X0116
log Bayes Factor = 12.7289
contains 3 variants:
rs760077
lBF = 9.611
Chr 1 : 155,178,782
rs3843518
lBF = 5.199
Chr 6 : 10,865,383
rs10974900
lBF = 5.182
Chr 9 : 4,987,958
What are variant clusters?
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K31.7 Polyp of stomach and duodenum
0.000 0.000 1.000
D45 Polycythaemia vera
0.000 0.012 0.988
E21.0 Primary hyperparathyroidism
0.000 0.018 0.982
D35.1 Parathyroid gland
0.000 0.045 0.955
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.084 0.916
E21.3 Hyperparathyroidism, unspecified
0.000 0.122 0.878
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.220 0.780
E21.2 Other hyperparathyroidism
0.000 0.276 0.724
E21.4 Other specified disorders of parathyroid gland
0.000 0.314 0.686
K51 Ulcerative colitis
0.000 0.324 0.676
K51.8 Other ulcerative colitis
0.000 0.338 0.662
K51.0 Ulcerative (chronic) enterocolitis
0.000 0.339 0.661
K50 Crohn's disease [regional enteritis]
0.000 0.361 0.639
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.363 0.637
K50.9 Crohn's disease, unspecified
0.000 0.364 0.636
K50-K52 Noninfective enteritis and colitis
0.000 0.364 0.636
K51.5 Mucosal proctocolitis
0.000 0.365 0.635
K51.4 Pseudopolyposis of colon
0.000 0.376 0.624
K50.1 Crohn's disease of large intestine
0.000 0.385 0.615
K51.3 Ulcerative (chronic) rectosigmoiditis
0.000 0.487 0.513
K51.1 Ulcerative (chronic) ileocolitis
0.000 0.493 0.507
K51.9 Ulcerative colitis, unspecified
0.000 0.563 0.437
K50.0 Crohn's disease of small intestine
0.000 0.568 0.432
D13.1 Stomach
0.000 0.636 0.364
K31 Other diseases of stomach and duodenum
0.000 0.691 0.309
K31.5 Obstruction of duodenum
0.000 0.700 0.300
K31.4 Gastric diverticulum
0.000 0.725 0.275
K31.6 Fistula of stomach and duodenum
0.000 0.730 0.270
K31.2 Hourglass stricture and stenosis of stomach
0.000 0.772 0.228
K50.8 Other Crohn's disease
0.000 0.772 0.228
K31.0 Acute dilatation of stomach
0.000 0.799 0.201
H43.3 Other vitreous opacities
0.000 0.837 0.163
K31.3 Pylorospasm, not elsewhere classified
0.000 0.838 0.161
K51.2 Ulcerative (chronic) proctitis
0.000 0.880 0.120
O75.2 Pyrexia during labour, not elsewhere classified
0.106 0.894 0.000
O75.7 Vaginal delivery following previous Caesarean section
0.105 0.895 0.000
T83.1 Mechanical complication of other urinary devices and implants
0.000 0.905 0.095
O75 Other complications of labour and delivery, not elsewhere classified
0.095 0.905 0.000
D35 Benign neoplasm of other and unspecified endocrine glands
0.000 0.917 0.083
O75.5 Delayed delivery after artificial rupture of membranes
0.069 0.931 0.000
O75.1 Shock during or following labour and delivery
0.068 0.932 0.000
O75.4 Other complications of obstetric surgery and procedures
0.068 0.932 0.000
O75.9 Complication of labour and delivery, unspecified
0.068 0.932 0.000
O75.3 Other infection during labour
0.065 0.934 0.000
O75.0 Maternal distress during labour and delivery
0.063 0.937 0.000
D35.3 Craniopharyngeal duct
0.000 0.940 0.060
D35.4 Pineal gland
0.000 0.940 0.060
D35.5 Carotid body
0.000 0.940 0.060
D35.6 Aortic body and other paraganglia
0.000 0.940 0.060
D35.7 Other specified endocrine glands
0.000 0.940 0.060
D35.8 Pluriglandular involvement
0.000 0.940 0.060
D35.9 Endocrine gland, unspecified
0.000 0.940 0.060
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes
0.060 0.940 0.000
D47.1 Chronic myeloproliferative disease
0.000 0.959 0.041
H43 Disorders of vitreous body
0.000 0.962 0.038
E20-E35 Disorders of other endocrine glands
0.000 0.964 0.036
K52 Other non-infective gastro-enteritis and colitis
0.000 0.967 0.033
D37-D48 Neoplasms of uncertain or unknown behaviour
0.000 0.968 0.032
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.000 0.968 0.032
E25 Adrenogenital disorders
0.000 0.968 0.032
D35.2 Pituitary gland
0.000 0.969 0.031
H43.8 Other disorders of vitreous body
0.000 0.969 0.031
E34 Other endocrine disorders
0.000 0.970 0.030
K52.3 Indeterminate colitis
0.000 0.970 0.030
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.971 0.029
E34.9 Endocrine disorder, unspecified
0.000 0.972 0.028
D47.4 Osteomyelofibrosis
0.000 0.973 0.027
E28 Ovarian dysfunction
0.000 0.973 0.027
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.000 0.973 0.027
D46 Myelodysplastic syndromes
0.000 0.973 0.027
E34.8 Other specified endocrine disorders
0.000 0.973 0.027
H43.9 Disorder of vitreous body, unspecified
0.000 0.974 0.026
E30 Disorders of puberty, not elsewhere classified
0.000 0.974 0.026
E32 Diseases of thymus
0.000 0.974 0.026
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.974 0.026
D46.9 Myelodysplastic syndrome, unspecified
0.000 0.974 0.026
E31 Polyglandular dysfunction
0.000 0.974 0.026
H43.0 Vitreous prolapse
0.000 0.975 0.025
E27 Other disorders of adrenal gland
0.000 0.975 0.025
Z90.3 Acquired absence of part of stomach
0.000 0.976 0.024
E27.2 Addisonian crisis
0.000 0.976 0.024
E28.2 Polycystic ovarian syndrome
0.000 0.976 0.024
H43.2 Crystalline deposits in vitreous body
0.000 0.976 0.024
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
0.000 0.977 0.023
K31.1 Adult hypertrophic pyloric stenosis
0.001 0.977 0.023
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]
0.000 0.977 0.023
D48.6 Breast
0.000 0.977 0.023
E25.8 Other adrenogenital disorders
0.000 0.977 0.023
E25.9 Adrenogenital disorder, unspecified
0.000 0.977 0.023
D39.7 Other female genital organs
0.000 0.977 0.023
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.000 0.977 0.023
D42 Neoplasm of uncertain or unknown behaviour of meninges
0.000 0.977 0.023
E24 Cushing's syndrome
0.000 0.977 0.023
E34.1 Other hypersecretion of intestinal hormones
0.000 0.978 0.022
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.978 0.022
E34.4 Constitutional tall stature
0.000 0.978 0.022
E34.5 Androgen resistance syndrome
0.000 0.978 0.022
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour
0.000 0.978 0.021
D46.2 Refractory anaemia with excess of blasts
0.000 0.979 0.021
E20 Hypoparathyroidism
0.000 0.979 0.021
D39.1 Ovary
0.000 0.980 0.020
E24.2 Drug-induced Cushing's syndrome
0.000 0.980 0.020
D39.0 Uterus
0.000 0.980 0.020
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified
0.000 0.980 0.020
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.980 0.020
E28.0 Oestrogen excess
0.000 0.980 0.020
E28.1 Androgen excess
0.000 0.980 0.020
E28.8 Other ovarian dysfunction
0.000 0.980 0.020
E28.9 Ovarian dysfunction, unspecified
0.000 0.980 0.020
D39.2 Placenta
0.000 0.980 0.020
D39.9 Female genital organ, unspecified
0.000 0.980 0.020
D46.0 Refractory anaemia without sideroblasts, so stated
0.000 0.980 0.019
D46.3 Refractory anaemia with excess of blasts with transformation
0.000 0.980 0.019
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
0.000 0.980 0.019
E30.0 Delayed puberty
0.000 0.981 0.019
E30.1 Precocious puberty
0.000 0.981 0.019
E30.8 Other disorders of puberty
0.000 0.981 0.019
E30.9 Disorder of puberty, unspecified
0.000 0.981 0.019
E32.0 Persistent hyperplasia of thymus
0.000 0.981 0.019
E32.1 Abscess of thymus
0.000 0.981 0.019
E32.8 Other diseases of thymus
0.000 0.981 0.019
E32.9 Disease of thymus, unspecified
0.000 0.981 0.019
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.981 0.019
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.981 0.019
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.981 0.019
D46.5 Refractory anaemia with multi-lineage dysplasia
0.000 0.981 0.019
E31.1 Polyglandular hyperfunction
0.000 0.981 0.019
E31.8 Other polyglandular dysfunction
0.000 0.981 0.019
E31.9 Polyglandular dysfunction, unspecified
0.000 0.981 0.019
D46.4 Refractory anaemia, unspecified
0.000 0.982 0.018
E31.0 Autoimmune polyglandular failure
0.000 0.982 0.018
D48.0 Bone and articular cartilage
0.000 0.982 0.018
C67.6 Ureteric orifice
0.018 0.982 0.000
K76.9 Liver disease, unspecified
0.000 0.982 0.018
E27.0 Other adrenocortical overactivity
0.000 0.982 0.018
E27.5 Adrenomedullary hyperfunction
0.000 0.982 0.018
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.983 0.017
D48.3 Retroperitoneum
0.000 0.983 0.017
E34.3 Short stature, not elsewhere classified
0.000 0.983 0.017
K52.2 Allergic and dietetic gastro-enteritis and colitis
0.000 0.983 0.017
E26 Hyperaldosteronism
0.000 0.983 0.017
E27.1 Primary adrenocortical insufficiency
0.000 0.983 0.017
D42.0 Cerebral meninges
0.000 0.983 0.016
D42.1 Spinal meninges
0.000 0.983 0.016
E24.1 Nelson's syndrome
0.000 0.983 0.016
E24.3 Ectopic ACTH syndrome
0.000 0.983 0.016
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.983 0.016
D46.7 Other myelodysplastic syndromes
0.000 0.984 0.016
E29 Testicular dysfunction
0.000 0.984 0.016
D48.1 Connective and other soft tissue
0.000 0.984 0.016
D42.9 Meninges, unspecified
0.000 0.984 0.016
D46.1 Refractory anaemia with sideroblasts
0.000 0.985 0.015
E20.0 Idiopathic hypoparathyroidism
0.000 0.985 0.015
E20.1 Pseudohypoparathyroidism
0.000 0.985 0.015
E20.8 Other hypoparathyroidism
0.000 0.985 0.015
D48.4 Peritoneum
0.000 0.985 0.015
H43-H45 Disorders of vitreous body and globe
0.000 0.985 0.015
E27.8 Other specified disorders of adrenal gland
0.000 0.985 0.015
E27.9 Disorder of adrenal gland, unspecified
0.000 0.985 0.015
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.000 0.985 0.015
D48.2 Peripheral nerves and autonomic nervous system
0.000 0.986 0.014
E24.0 Pituitary-dependent Cushing's disease
0.000 0.986 0.014
K52.0 Gastro-enteritis and colitis due to radiation
0.000 0.986 0.014
E28.3 Primary ovarian failure
0.000 0.986 0.014
E24.9 Cushing's syndrome, unspecified
0.000 0.987 0.013
D38.0 Larynx
0.000 0.988 0.012
E26.1 Secondary hyperaldosteronism
0.000 0.988 0.012
E26.8 Other hyperaldosteronism
0.000 0.988 0.012
E24.8 Other Cushing's syndrome
0.000 0.988 0.012
E29.0 Testicular hyperfunction
0.000 0.988 0.012
E29.8 Other testicular dysfunction
0.000 0.988 0.012
H45 Disorders of vitreous body and globe in diseases classified elsewhere
0.000 0.989 0.011
E29.9 Testicular dysfunction, unspecified
0.000 0.989 0.011
Z76.3 Healthy person accompanying sick person
0.000 0.989 0.011
D38.3 Mediastinum
0.000 0.989 0.011
D38.4 Thymus
0.000 0.989 0.011
D38.6 Respiratory organ, unspecified
0.000 0.989 0.011
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.000 0.989 0.010
D38.5 Other respiratory organs
0.000 0.989 0.010
D47.3 Essential (haemorrhagic) thrombocythaemia
0.000 0.990 0.010
H44 Disorders of globe
0.000 0.990 0.010
Z76.9 Persons encountering health services in unspecified circumstances
0.000 0.990 0.010
Z76 Persons encountering health services in other circumstances
0.000 0.990 0.010
D48.7 Other specified sites
0.000 0.990 0.010
E26.0 Primary hyperaldosteronism
0.000 0.990 0.010
E20.9 Hypoparathyroidism, unspecified
0.000 0.990 0.010
H44.8 Other disorders of globe
0.000 0.991 0.009
Z76.8 Persons encountering health services in other specified circumstances
0.000 0.991 0.009
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.000 0.991 0.009
H44.5 Degenerated conditions of globe
0.000 0.991 0.009
H44.2 Degenerative myopia
0.000 0.991 0.009
E34.0 Carcinoid syndrome
0.000 0.991 0.009
D38.2 Pleura
0.000 0.991 0.009
H45.0 Vitreous haemorrhage in diseases classified elsewhere
0.000 0.992 0.008
H45.1 Endophthalmitis in diseases classified elsewhere
0.000 0.992 0.008
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere
0.000 0.992 0.008
D47.2 Monoclonal gammopathy
0.000 0.992 0.008
D40.9 Male genital organ, unspecified
0.000 0.992 0.008
H44.1 Other endophthalmitis
0.000 0.992 0.008
H44.3 Other degenerative disorders of globe
0.000 0.992 0.008
H44.6 Retained (old) intraocular foreign body, magnetic
0.000 0.992 0.008
T45.0 Antiallergic and antiemetic drugs
0.008 0.992 0.000
D43.4 Spinal cord
0.000 0.992 0.008
K52.8 Other specified non-infective gastro-enteritis and colitis
0.000 0.992 0.008
Z92.0 Personal history of contraception
0.000 0.992 0.008
Z76.0 Issue of repeat prescription
0.000 0.992 0.007
Z76.1 Health supervision and care of foundling
0.000 0.992 0.007
Z76.2 Health supervision and care of other healthy infant and child
0.000 0.992 0.007
Z76.4 Other boarder in health-care facility
0.000 0.992 0.007
Z76.5 Malingerer [conscious situation]
0.000 0.992 0.007
E26.9 Hyperaldosteronism, unspecified
0.001 0.993 0.007
Z22.5 Carrier of viral hepatitis
0.007 0.993 0.000
D11.0 Parotid gland
0.007 0.993 0.000
H50.9 Strabismus, unspecified
0.000 0.993 0.007
H44.7 Retained (old) intraocular foreign body, nonmagnetic
0.000 0.993 0.007
D40.1 Testis
0.000 0.993 0.007
E22 Hyperfunction of pituitary gland
0.000 0.993 0.007
D43.3 Cranial nerves
0.000 0.993 0.007
D43.7 Other parts of central nervous system
0.000 0.993 0.007
D43.9 Central nervous system, unspecified
0.000 0.993 0.007
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.993 0.007
T45.2 Vitamins, not elsewhere classified
0.007 0.993 0.000
H44.4 Hypotony of eye
0.000 0.994 0.006
H44.9 Disorder of globe, unspecified
0.000 0.994 0.006
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.006 0.994 0.000
D40.7 Other male genital organs
0.000 0.994 0.006
E07.9 Disorder of thyroid, unspecified
0.006 0.994 0.000
N34.2 Other urethritis
0.006 0.994 0.000
B19.9 Unspecified viral hepatitis without coma
0.006 0.994 0.000
D13 Benign neoplasm of other and ill-defined parts of digestive system
0.000 0.994 0.006
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.006 0.994 0.000
D43.1 Brain, infratentorial
0.000 0.994 0.005
C67.3 Anterior wall of bladder
0.005 0.995 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.005 0.995 0.000
B17 Other acute viral hepatitis
0.005 0.995 0.000
C67 Malignant neoplasm of bladder
0.005 0.995 0.000
E22.8 Other hyperfunction of pituitary gland
0.000 0.995 0.005
B19 Unspecified viral hepatitis
0.005 0.995 0.000
B18.1 Chronic viral hepatitis B without delta-agent
0.005 0.995 0.000
B18 Chronic viral hepatitis
0.005 0.995 0.000
E23 Hypofunction and other disorders of pituitary gland
0.000 0.995 0.005
B17.8 Other specified acute viral hepatitis
0.005 0.995 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.005 0.995 0.000
D26.0 Cervix uteri
0.005 0.995 0.000
G43.1 Migraine with aura [classical migraine]
0.000 0.995 0.005
B17.9 Acute viral hepatitis, unspecified
0.005 0.995 0.000
D13.3 Other and unspecified parts of small intestine
0.000 0.995 0.005
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.000 0.995 0.005
B15-B19 Viral hepatitis
0.005 0.995 0.000
E29.1 Testicular hypofunction
0.000 0.995 0.005
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.005 0.995 0.000
T45.3 Enzymes, not elsewhere classified
0.005 0.995 0.000
T45.4 Iron and its compounds
0.005 0.995 0.000
T45.6 Fibrinolysis-affecting drugs
0.005 0.995 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.005 0.995 0.000
T45.8 Other primarily systemic and haematological agents
0.005 0.995 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.005 0.995 0.000
H65.9 Nonsuppurative otitis media, unspecified
0.005 0.995 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.995 0.004
T45.5 Anticoagulants
0.005 0.995 0.000
D48.5 Skin
0.000 0.995 0.005
D75.1 Secondary polycythaemia
0.000 0.995 0.005
B18.9 Chronic viral hepatitis, unspecified
0.004 0.995 0.000
S51.9 Open wound of forearm, part unspecified
0.004 0.996 0.000
B17.2 Acute hepatitis E
0.004 0.996 0.000
C67.5 Bladder neck
0.004 0.996 0.000
W18.3 Sports and athletics area
0.000 0.996 0.004
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.004 0.996 0.000
O75.8 Other specified complications of labour and delivery
0.004 0.996 0.001
M00.96 Pyogenic arthritis, unspecified (Lower leg)
0.004 0.996 0.000
T44.0 Anticholinesterase agents
0.004 0.996 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.004 0.996 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.004 0.996 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.004 0.996 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.004 0.996 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.004 0.996 0.000
B17.0 Acute delta-(super) infection of hepatitis B carrier
0.004 0.996 0.000
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified
0.004 0.996 0.000
C67.0 Trigone of bladder
0.004 0.996 0.000
C67.7 Urachus
0.004 0.996 0.000
C67.8 Overlapping lesion of bladder
0.004 0.996 0.000
D13.9 Ill-defined sites within the digestive system
0.000 0.996 0.004
A41.1 Septicaemia due to other specified staphylococcus
0.000 0.996 0.004
B19.0 Unspecified viral hepatitis with coma
0.004 0.996 0.000
C66 Malignant neoplasm of ureter
0.004 0.996 0.000
B18.0 Chronic viral hepatitis B with delta-agent
0.004 0.996 0.000
B18.8 Other chronic viral hepatitis
0.004 0.996 0.000
E23.1 Drug-induced hypopituitarism
0.000 0.996 0.004
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.996 0.004
B17.1 Acute hepatitis C
0.004 0.996 0.000
C67.1 Dome of bladder
0.004 0.996 0.000
B18.2 Chronic viral hepatitis C
0.004 0.996 0.000
D13.5 Extrahepatic bile ducts
0.000 0.996 0.004
D44.2 Parathyroid gland
0.000 0.996 0.004
D44.5 Pineal gland
0.000 0.996 0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.004 0.996 0.000
D44.4 Craniopharyngeal duct
0.000 0.996 0.004
H92.1 Otorrhoea
0.004 0.996 0.000
B16 Acute hepatitis B
0.004 0.996 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.004 0.996 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.004 0.996 0.000
F23.9 Acute and transient psychotic disorder, unspecified
0.004 0.996 0.000
K66.8 Other specified disorders of peritoneum
0.004 0.996 0.000
M00.9 Pyogenic arthritis, unspecified
0.004 0.996 0.000
D44.6 Carotid body
0.000 0.996 0.003
M00.92 Pyogenic arthritis, unspecified (Upper arm)
0.004 0.996 0.000
T47.6 Antidiarrhoeal drugs
0.004 0.996 0.000
E22.0 Acromegaly and pituitary gigantism
0.000 0.996 0.004
E73.9 Lactose intolerance, unspecified
0.000 0.996 0.004
T45.1 Antineoplastic and immunosuppressive drugs
0.003 0.997 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.003 0.997 0.000
D44.9 Endocrine gland, unspecified
0.000 0.997 0.003
Y41.5 Antiviral drugs
0.003 0.997 0.000
T17.9 Foreign body in respiratory tract, part unspecified
0.003 0.997 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.003 0.997 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.003 0.997 0.000
X47.0 Home
0.000 0.997 0.003
M00.91 Pyogenic arthritis, unspecified (Shoulder region)
0.003 0.997 0.000
D43.0 Brain, supratentorial
0.000 0.997 0.003
T36-T50 Poisoning by drugs, medicaments and biological substances
0.003 0.997 0.000
M00.93 Pyogenic arthritis, unspecified (Forearm)
0.003 0.997 0.000
T50.8 Diagnostic agents
0.003 0.997 0.000
D44.1 Adrenal gland
0.000 0.997 0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.003 0.997 0.000
D40.0 Prostate
0.000 0.997 0.003
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria
0.000 0.997 0.003
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
0.000 0.997 0.003
E23.7 Disorder of pituitary gland, unspecified
0.000 0.997 0.003
D13.4 Liver
0.000 0.997 0.003
T47.1 Other antacids and anti-gastric-secretion drugs
0.003 0.997 0.000
D13.7 Endocrine pancreas
0.000 0.997 0.003
T47.4 Other laxatives
0.003 0.997 0.000
D44.8 Pluriglandular involvement
0.000 0.997 0.003
T47.0 Histamine H(2)-receptor antagonists
0.003 0.997 0.000
C64-C68 Malignant neoplasms of urinary tract
0.003 0.997 0.000
D44.7 Aortic body and other paraganglia
0.000 0.997 0.003
D44.0 Thyroid gland
0.000 0.997 0.003
H44.0 Purulent endophthalmitis
0.000 0.997 0.003
T50.0 Mineralocorticoids and their antagonists
0.003 0.997 0.000
T50.1 Loop [high-ceiling] diuretics
0.003 0.997 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.003 0.997 0.000
T50.5 Appetite depressants
0.003 0.997 0.000
T50.7 Analeptics and opioid receptor antagonists
0.003 0.997 0.000
B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma
0.003 0.997 0.000
B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma
0.003 0.997 0.000
B16.2 Acute hepatitis B without delta-agent with hepatic coma
0.003 0.997 0.000
M00.99 Pyogenic arthritis, unspecified (Site unspecified)
0.003 0.997 0.000
T47.3 Saline and osmotic laxatives
0.003 0.997 0.000
T47.5 Digestants
0.003 0.997 0.000
T47.7 Emetics
0.003 0.997 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.003 0.997 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.003 0.997 0.000
C65 Malignant neoplasm of renal pelvis
0.003 0.997 0.000
C67.4 Posterior wall of bladder
0.003 0.997 0.000
I70.10 Atherosclerosis of renal artery (without gangrene)
0.003 0.997 0.000
I70.00 Atherosclerosis of aorta (without gangrene)
0.003 0.997 0.000
T46.1 Calcium-channel blockers
0.003 0.997 0.000
T47.2 Stimulant laxatives
0.003 0.997 0.000
B16.9 Acute hepatitis B without delta-agent and without hepatic coma
0.003 0.997 0.000
M00.98 Pyogenic arthritis, unspecified (Other)
0.003 0.997 0.000
B15 Acute hepatitis A
0.003 0.997 0.000
M21.17 Varus deformity, not elsewhere classified (Ankle and foot)
0.000 0.997 0.003
M00.90 Pyogenic arthritis, unspecified (Multiple sites)
0.003 0.997 0.000
E22.1 Hyperprolactinaemia
0.000 0.997 0.003
T36.3 Macrolides
0.003 0.997 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.003 0.997 0.000
L23.1 Allergic contact dermatitis due to adhesives
0.003 0.997 0.000
T37.0 Sulphonamides
0.003 0.997 0.000
T37.1 Antimycobacterial drugs
0.003 0.997 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.003 0.997 0.000
T37.3 Other antiprotozoal drugs
0.003 0.997 0.000
T37.4 Anthelminthics
0.003 0.997 0.000
T37.5 Antiviral drugs
0.003 0.997 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.003 0.997 0.000
T36 Poisoning by systemic antibiotics
0.003 0.997 0.000
G82.2 Paraplegia, unspecified
0.003 0.997 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.003 0.997 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.003 0.997 0.000
E23.2 Diabetes insipidus
0.000 0.997 0.003
D41.3 Urethra
0.000 0.997 0.002
D41.7 Other urinary organs
0.000 0.997 0.002
D41.9 Urinary organ, unspecified
0.000 0.997 0.002
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.997 0.003
T50.4 Drugs affecting uric acid metabolism
0.003 0.997 0.000
D13.2 Duodenum
0.000 0.997 0.003
M00.94 Pyogenic arthritis, unspecified (Hand)
0.003 0.997 0.000
R10.0 Acute abdomen
0.000 0.997 0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.002 0.997 0.000
D26.9 Uterus, unspecified
0.003 0.997 0.000
N48.0 Leukoplakia of penis
0.003 0.997 0.000
F23 Acute and transient psychotic disorders
0.002 0.997 0.000
D35.0 Adrenal gland
0.000 0.998 0.002
D41.1 Renal pelvis
0.000 0.998 0.002
M00 Pyogenic arthritis
0.002 0.998 0.000
D26 Other benign neoplasms of uterus
0.002 0.998 0.000
K52.1 Toxic gastro-enteritis and colitis
0.000 0.998 0.002
S19.9 Unspecified injury of neck
0.002 0.998 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.002 0.998 0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia
0.002 0.998 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.002 0.998 0.000
R46.8 Other symptoms and signs involving appearance and behaviour
0.002 0.998 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.002 0.998 0.000
D37.1 Stomach
0.000 0.998 0.002
F23.3 Other acute predominantly delusional psychotic disorders
0.002 0.998 0.000
K82.1 Hydrops of gallbladder
0.000 0.998 0.002
B15.0 Hepatitis A with hepatic coma
0.002 0.998 0.000
O23.4 Unspecified infection of urinary tract in pregnancy
0.000 0.998 0.002
T36.4 Tetracyclines
0.002 0.998 0.000
M00.0 Staphylococcal arthritis and polyarthritis
0.002 0.998 0.000
M00.95 Pyogenic arthritis, unspecified (Pelvic region and thigh)
0.002 0.998 0.000
T46.7 Peripheral vasodilators
0.002 0.998 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.002 0.998 0.000
D11 Benign neoplasm of major salivary glands
0.002 0.998 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.002 0.998 0.000
T36.2 Chloramphenicol group
0.002 0.998 0.000
T36.5 Aminoglycosides
0.002 0.998 0.000
T36.6 Rifamycins
0.002 0.998 0.000
T36.7 Antifungal antibiotics, systemically used
0.002 0.998 0.000
T36.8 Other systemic antibiotics
0.002 0.998 0.000
T36.9 Systemic antibiotic, unspecified
0.002 0.998 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.002 0.998 0.000
M71.16 Other infective bursitis (Lower leg)
0.002 0.998 0.000
T49.1 Antipruritics
0.002 0.998 0.000
T49.2 Local astringents and local detergents
0.002 0.998 0.000
T49.3 Emollients, demulcents and protectants
0.002 0.998 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.002 0.998 0.000
T49.5 Ophthalmological drugs and preparations
0.002 0.998 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.002 0.998 0.000
T49.7 Dental drugs, topically applied
0.002 0.998 0.000
T49.8 Other topical agents
0.002 0.998 0.000
T49.9 Topical agent, unspecified
0.002 0.998 0.000
M00.01 Staphylococcal arthritis and polyarthritis (Shoulder region)
0.002 0.998 0.000
T41.0 Inhaled anaesthetics
0.002 0.998 0.000
T41.1 Intravenous anaesthetics
0.002 0.998 0.000
T41.2 Other and unspecified general anaesthetics
0.002 0.998 0.000
T41.3 Local anaesthetics
0.002 0.998 0.000
T41.4 Anaesthetic, unspecified
0.002 0.998 0.000
T41.5 Therapeutic gases
0.002 0.998 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.002 0.998 0.000
B27.9 Infectious mononucleosis, unspecified
0.002 0.998 0.000
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot
0.002 0.998 0.000
O69.8 Labour and delivery complicated by other cord complications
0.002 0.998 0.000
D26.7 Other parts of uterus
0.002 0.998 0.000
T59.8 Other specified gases, fumes and vapours
0.000 0.998 0.002
D89.2 Hypergammaglobulinaemia, unspecified
0.002 0.998 0.000
M22.4 Chondromalacia patellae
0.002 0.998 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.002 0.998 0.000
M00.8 Arthritis and polyarthritis due to other specified bacterial agents
0.002 0.998 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.002 0.998 0.000
D13.6 Pancreas
0.001 0.998 0.001
F23.2 Acute schizophrenia-like psychotic disorder
0.002 0.998 0.000
F23.8 Other acute and transient psychotic disorders
0.002 0.998 0.000
O87.0 Superficial thrombophlebitis in the puerperium
0.002 0.998 0.000
I70.1 Atherosclerosis of renal artery
0.002 0.998 0.000
L23 Allergic contact dermatitis
0.002 0.998 0.000
I70.0 Atherosclerosis of aorta
0.002 0.998 0.000
M00.1 Pneumococcal arthritis and polyarthritis
0.002 0.998 0.000
M00.2 Other streptococcal arthritis and polyarthritis
0.002 0.998 0.000
L23.3 Allergic contact dermatitis due to drugs in contact with the skin
0.002 0.998 0.000
B50.9 Plasmodium falciparum malaria, unspecified
0.000 0.998 0.002
K31.8 Other specified diseases of stomach and duodenum
0.000 0.998 0.002
L23.5 Allergic contact dermatitis due to other chemical products
0.002 0.998 0.000
M10.90 Gout, unspecified (Multiple sites)
0.002 0.998 0.000
T48.5 Anti-common-cold drugs
0.002 0.998 0.000
W18 Other fall on same level
0.000 0.998 0.002
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia
0.002 0.998 0.000
C68 Malignant neoplasm of other and unspecified urinary organs
0.002 0.998 0.000
E07 Other disorders of thyroid
0.002 0.998 0.000
G83.9 Paralytic syndrome, unspecified
0.002 0.998 0.000
T48.0 Oxytocic drugs
0.002 0.998 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.002 0.998 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.002 0.998 0.000
T48.3 Antitussives
0.002 0.998 0.000
T48.4 Expectorants
0.002 0.998 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.002 0.998 0.000
O20.8 Other haemorrhage in early pregnancy
0.002 0.998 0.000
M00.00 Staphylococcal arthritis and polyarthritis (Multiple sites)
0.002 0.998 0.000
M00.02 Staphylococcal arthritis and polyarthritis (Upper arm)
0.002 0.998 0.000
M00.03 Staphylococcal arthritis and polyarthritis (Forearm)
0.002 0.998 0.000
M00.04 Staphylococcal arthritis and polyarthritis (Hand)
0.002 0.998 0.000
M00.05 Staphylococcal arthritis and polyarthritis (Pelvic region and thigh)
0.002 0.998 0.000
M00.06 Staphylococcal arthritis and polyarthritis (Lower leg)
0.002 0.998 0.000
M00.07 Staphylococcal arthritis and polyarthritis (Ankle and foot)
0.002 0.998 0.000
M00.08 Staphylococcal arthritis and polyarthritis (Other)
0.002 0.998 0.000
M00.09 Staphylococcal arthritis and polyarthritis (Site unspecified)
0.002 0.998 0.000
M10.06 Idiopathic gout (Lower leg)
0.002 0.998 0.000
W17.4 Street and highway
0.002 0.998 0.000
C02.1 Border of tongue
0.002 0.998 0.000
D41.2 Ureter
0.000 0.998 0.002
W79.2 School, other institution and public administrative area
0.002 0.998 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.002 0.998 0.000
C02.9 Tongue, unspecified
0.002 0.998 0.000
E23.6 Other disorders of pituitary gland
0.000 0.998 0.002
W18.1 Residential institution
0.000 0.998 0.002
H06.2 Dysthyroid exophthalmos
0.002 0.998 0.000
Y41.0 Sulphonamides
0.002 0.998 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.002 0.998 0.000
Q28.2 Arteriovenous malformation of cerebral vessels
0.002 0.998 0.000
T75.4 Effects of electric current
0.000 0.998 0.002
M10.04 Idiopathic gout (Hand)
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.